IL17A and neoplasm: Furthermore, we found that Vγ1 γδ T cell depletion decreased IL-17A secretion by CT26 tumour-infiltrating cells, with similar IL-17A secretion seen after treatment with anti-BTNL2 and controls (Fig. 3f).